Clostridioides difficile Infection
- PMID: 30285209
- PMCID: PMC6524133
- DOI: 10.7326/AITC201810020
Clostridioides difficile Infection
Abstract
Clostridioides difficile (formerly Clostridium difficile) infection is the most frequently identified health care-associated infection in the United States. C difficile has also emerged as a cause of community-associated diarrhea, resulting in increased incidence of community-associated infection. Clinical illness ranges in severity from mild diarrhea to fulminant colitis and death. Appropriate management of infection requires understanding of the various diagnostic assays and therapeutic options as well as relevant measures to infection prevention. This article provides updated recommendations regarding the prevention, diagnosis, and treatment of incident and recurrent C difficile infection.
Figures
Similar articles
-
Recent developments in the management of recurrent Clostridioides difficile infection.Anaerobe. 2020 Apr;62:102108. doi: 10.1016/j.anaerobe.2019.102108. Epub 2019 Oct 10. Anaerobe. 2020. PMID: 31606481 Review.
-
Current Approaches to Treat and Prevent Recurrence of Clostridioides difficile.Gastroenterol Clin North Am. 2025 Jun;54(2):259-275. doi: 10.1016/j.gtc.2025.02.005. Epub 2025 Mar 24. Gastroenterol Clin North Am. 2025. PMID: 40348487 Review.
-
Clostridioides difficile Colitis.Surg Clin North Am. 2024 Jun;104(3):545-556. doi: 10.1016/j.suc.2023.11.005. Epub 2023 Dec 26. Surg Clin North Am. 2024. PMID: 38677819 Review.
-
Clostridioides difficile Infections: Prevention and Treatment Strategies.Adv Exp Med Biol. 2024;1449:175-186. doi: 10.1007/978-3-031-58572-2_11. Adv Exp Med Biol. 2024. PMID: 39060738 Review.
-
Critical Care Management of the Patient with Clostridioides difficile.Crit Care Med. 2021 Jan 1;49(1):127-139. doi: 10.1097/CCM.0000000000004739. Crit Care Med. 2021. PMID: 33156122 Free PMC article. Review.
Cited by
-
Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials.Front Pharmacol. 2024 Oct 17;15:1430724. doi: 10.3389/fphar.2024.1430724. eCollection 2024. Front Pharmacol. 2024. PMID: 39484168 Free PMC article.
-
Rate and predictors of 30-day readmission for clostridiodes difficile: a United States analysis.Ann Med. 2022 Dec;54(1):150-158. doi: 10.1080/07853890.2021.2023211. Ann Med. 2022. PMID: 34989297 Free PMC article.
-
Clostridioides difficile Infection: Landscape and Microbiome Therapeutics.Gastroenterol Hepatol (N Y). 2023 Jun;19(6):319-328. Gastroenterol Hepatol (N Y). 2023. PMID: 37706187 Free PMC article.
-
A Metatranscriptomics Survey of Microbial Diversity on Surfaces Post-Intervention of cleanSURFACES® Technology in an Intensive Care Unit.Front Cell Infect Microbiol. 2021 Jul 20;11:705593. doi: 10.3389/fcimb.2021.705593. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34354962 Free PMC article.
-
Antibiotic Exposure and Risk of Allograft Rejection and Survival After Liver Transplant: An Observational Cohort Study From a Tertiary Referral Centre.Transpl Infect Dis. 2025 May-Jun;27(3):e70026. doi: 10.1111/tid.70026. Epub 2025 Mar 28. Transpl Infect Dis. 2025. PMID: 40153422 Free PMC article.
References
-
- Bartlett JG. Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis. 1994;18 Suppl 4:S265–72. - PubMed
-
- Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg. 2007; 142:624–31. - PubMed
-
- Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442–9. - PubMed
-
- Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366: 1079–84. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources